Skip to content

The design and research of antibiotic application in patients with high-risk of sepsis

The design and research of antibiotic application in patients with high-risk of sepsis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009776
Enrollment
Unknown
Registered
2016-11-08
Start date
2016-11-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

control group: preventive antibiotic treatment routinely
Early warning equations group:According to the early warning equation to decide whether to give preventive antibiotic treatment

Sponsors

Department of Anesthesiology, the First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The critical ill patients in ICU

Exclusion criteria

Exclusion criteria: 1) patients with acquired immunodeficiency syndrome; 2) patients treated with chemotherapy in the first eight weeks; 3) patients received immunosuppressive therapy after organ transplant surgery; 4) patients treated with glucocorticoids in the first four weeks.

Design outcomes

Primary

MeasureTime frame
The incidence rate of sepsis;mortality rate of sepsis;length of stay in hospital;hospitalization cost;SOFA score;Antibiotics usage;APACHEII score;

Countries

China

Contacts

Public ContactXiangming Fang

Department of Anesthesiology, the First Affiliated Hospital, Zhejiang University School of Medicine

xiangming_fang@163.com+86 13857161019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026